Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
5581690 | Clinical Lymphoma Myeloma and Leukemia | 2017 | 7 Pages |
Abstract
A minority of patients with cHL who achieve CR after auto-HCT will ultimately relapse. Surveillance imaging detected approximately half of relapses; however, outcomes were similar for those whose relapse was detected using routine surveillance imaging versus detected clinically in between surveillance imaging studies. There appears to be limited utility for routine surveillance imaging in cHL patients who achieve CR after auto-HCT.
Related Topics
Health Sciences
Medicine and Dentistry
Anesthesiology and Pain Medicine
Authors
Jonathan T. Kapke, Narendranath Epperla, Namrata Shah, Kristin Richardson, George Carrum, Parameswaran N. Hari, Sai R. Pingali, Mehdi Hamadani, Reem Karmali, Timothy S. Fenske,